Dopamine receptor
Dopamine receptors are a class of metabotropic G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS).
Dopamine Receptor Press Articles
Reference & Research Book News - Dopamine-glutamate interactions in the basal ganglia
Posted by admin / Under Dopamine Receptor
April 1, 2012 --
Dopamine-glutamate interactions in the basal ganglia.
Ed. by Susan Jones.
CRC Press
2012
260 pages
...
Published on Saturday 26th of May 2012 04:52:55 AM
Journal of Psychoactive Drugs - Sex, drugs, and rock 'N' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms
Posted by admin / Under Dopamine Receptor
March 1, 2012 --
The role of dopaminergic pathways in the reward circuitry of the brain is well established. Most drugs of abuse induce a preferential release...
Published on Saturday 26th of May 2012 04:52:55 AM
PR Newswire - Children with Certain Dopamine System Gene Variants Respond Better to ADHD Drug
Posted by admin / Under Dopamine Receptor
October 21, 2011 --
CINCINNATI, Oct. 21, 2011 /PRNewswire-USNewswire/ -- Children with certain dopamine system gene variants have an improved response to...
Published on Saturday 26th of May 2012 04:52:55 AM
Market Wire - Antipsychotics Reached $24 Billion in 2010
Posted by admin / Under Dopamine Receptor
August 1, 2011 --
MarketResearch.com has announced the addition of the new report "The CNS Market Outlook to 2016," to their collection of Pharmaceuticals...
Published on Saturday 26th of May 2012 04:52:55 AM
National Institutes of Health: News and Events - Receptor limits the rewarding effects of food and cocaine
Posted by admin / Under Dopamine Receptor
July 11, 2011 --
Researchers have long known that dopamine, a brain chemical that plays important roles in the control of normal movement, and in pleasure,...
Published on Saturday 26th of May 2012 04:52:55 AM
Market Wire - Biotie Announces Start of Phase 2b Trial of SYN115 in Parkinson's Disease
Posted by admin / Under Dopamine Receptor
April 7, 2011 --
Biotie Therapies Corp., a development stage company focused on diseases of the central nervous system, today announced the start of a Phase 2b...
Published on Saturday 26th of May 2012 04:52:55 AM
Nordic Business Report - -Finnish Biotie launches phase IIb trial for Parkinson's disease
Posted by admin / Under Dopamine Receptor
April 7, 2011 --
NORDIC BUSINESS REPORT-April 7, 2011--Finnish Biotie launches phase IIb trial for Parkinson's disease(C)2011 M2 COMMUNICATIONS...
Published on Saturday 26th of May 2012 04:52:55 AM
Environmental Health Perspectives - Hemoglobin, lead exposure, and intelligence quotient: effect modification by the DRD2 Taq IA polymorphism
Posted by admin / Under Dopamine Receptor
January 1, 2011 --
BACKGROUND: Anemia and lead exposure remain significant public health issues in many parts of the world, often occurring together. Animal...
Published on Saturday 26th of May 2012 04:52:55 AM
Annals of the American Psychotherapy Association - Reseacher finds vicious cycle in overeating and obesity
Posted by admin / Under Dopamine Receptor
September 22, 2010 --
[ILLUSTRATION OMITTED]
New research provides evidence of the vicious cycle created when an obese individual overeats to compensate...
Published on Saturday 26th of May 2012 04:52:55 AM
Archives of Neuropsychiatry - Long-term effects of olanzapine in various movement disorders/ Cesitli hareket bozukluklarinda olanzapin'in uzun sureli etkileri
Posted by admin / Under Dopamine Receptor
September 1, 2010 --
Introduction
Dopamine receptor blocking agents (neuroleptics) are effective drugs for hyperkinetic movement disorders (1,2). However,...
Published on Saturday 26th of May 2012 04:52:55 AM
Share this!